Envoy Therapeutics' Grant - II Round

Envoy Therapeutics raised a round of funding on July 11, 2011. Investors include The Michael J. Fox Foundation.

Envoy Therapeutics aims to discover new drugs with efficacy and fewer side effects than existing treatments. The companys bacTRAP technology enables the identification of proteins in vivo that are pro…

Articles about Envoy Therapeutics' Grant - II Round: